Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inflammatory Breast Cancer Stage IV”

46 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 46 results

Early research (Phase 1)WithdrawnNCT05093387
What this trial is testing

SGT-53, Carboplatin, and Pembrolizumab for the Treatment of Metastatic Triple Negative Inflammatory Breast Cancer

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Breast Inflammatory CarcinomaMetastatic Triple-Negative Breast Carcinoma+1 more
Northwestern University
Not applicableStudy completedNCT00033397
What this trial is testing

Diagnostic Procedures in Women With Locally Advanced Breast Cancer Who Are Receiving Chemotherapy Before Breast Cancer Surgery

Who this might be right for
Breast Cancer
Alliance for Clinical Trials in Oncology 360
Testing effectiveness (Phase 2)Active Not RecruitingNCT02411656
What this trial is testing

Pembrolizumab in Treating Patients With Stage IV Metastatic or Recurrent Inflammatory Breast Cancer or Triple-Negative Breast Cancer Who Have Achieved Clinical Response or Stable Disease to Prior Chemotherapy

Who this might be right for
EdemaErythemaEstrogen Receptor Negative+6 more
M.D. Anderson Cancer Center 71
Not applicableStudy completedNCT01048918
What this trial is testing

Characterization of Circulating Tumor Cells (CTC-s) in Patients With Locally Advanced or Metastatic Stage IV Breast Cancer

Who this might be right for
Locally Advanced Breast CancerMetastatic (Stage IV) Breast CancerStage III-IV Breast Cancer or Inflammatory
City of Hope Medical Center 280
Testing effectiveness (Phase 2)Ended earlyNCT02892734
What this trial is testing

Ipilimumab and Nivolumab in Treating Patients With Recurrent Stage IV HER2 Negative Inflammatory Breast Cancer

Who this might be right for
HER2/Neu NegativeRecurrent Inflammatory Breast CarcinomaStage IV Breast Cancer+1 more
Northwestern University 3
Testing effectiveness (Phase 2)Active Not RecruitingNCT04215146
What this trial is testing

Assess Overall Response Rate by Inducing an Inflammatory Phenotype in Metastatic BReast cAnCEr With the Oncolytic Reovirus PeLareorEp in CombinaTion With Anti-PD-L1 Avelumab and Paclitaxel - BRACELET-1 Study

Who this might be right for
Breast Cancer Metastatic
Oncolytics Biotech 48
Early research (Phase 1)Study completedNCT00004074
What this trial is testing

Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu

Who this might be right for
Advanced Adult Primary Liver CancerAnaplastic Thyroid CancerBone Metastases+124 more
National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)Study completedNCT00182793
What this trial is testing

Combination Chemotherapy With or Without Trastuzumab Followed By an Autologous Stem Cell Transplant and Radiation Therapy in Treating Patients With Stage III or Stage IV Breast Cancer

Who this might be right for
Breast Cancer
City of Hope Medical Center 32
Early research (Phase 1)Study completedNCT02900664
What this trial is testing

PDR001 in Combination With CJM112, EGF816, Ilaris® (Canakinumab) or Mekinist® (Trametinib)

Who this might be right for
Colorectal Cancer, Triple Negative Breast Cancer, NSCLC - Adenocarcinoma
Novartis Pharmaceuticals 283
Testing effectiveness (Phase 2)Active Not RecruitingNCT01730833
What this trial is testing

Pertuzumab, Trastuzumab, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With HER2-Positive Advanced Breast Cancer

Who this might be right for
HER2-positive Breast CancerRecurrent Breast CancerStage IIA Breast Cancer+7 more
City of Hope Medical Center 63
Testing effectiveness (Phase 2)Study completedNCT00006110
What this trial is testing

Multimodality Treatment for Women With Stage II, Stage III, or Stage IV Breast Cancer

Who this might be right for
Breast Cancer
UNC Lineberger Comprehensive Cancer Center 82
Early research (Phase 1)Study completedNCT00005842
What this trial is testing

Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Cancer
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Ended earlyNCT05041101
What this trial is testing

Grapiprant and Eribulin for the Treatment of Metastatic Inflammatory Breast Cancer

Who this might be right for
Breast Inflammatory CarcinomaRecurrent Breast Inflammatory CarcinomaStage IV Breast Inflammatory Carcinoma
M.D. Anderson Cancer Center 6
Not applicableUnknownNCT00094133
What this trial is testing

Hypnosis in Treating Hot Flashes in Breast Cancer Survivors

Who this might be right for
Breast CancerCancer SurvivorHot Flashes
Scott and White Hospital & Clinic 60
Not applicableWithdrawnNCT06057636
What this trial is testing

Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study

Who this might be right for
Breast CancerInflammatory Breast Cancer Stage IVInflammatory Breast Neoplasms+2 more
The University of Tennessee, Knoxville
Testing effectiveness (Phase 2)Study completedNCT00005798
What this trial is testing

Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer

Who this might be right for
Breast Cancer
H. Lee Moffitt Cancer Center and Research Institute 209
Testing effectiveness (Phase 2)Study completedNCT00001193
What this trial is testing

A Multimodality Treatment Approach to Patients With Inflammatory Cancer of the Breast and Locally Advanced Non-Inflammatory Stage III Breast Cancer and Stage IV Breast Cancer

Who this might be right for
Breast NeoplasmsNeoplasm Metastasis
National Cancer Institute (NCI) 200
Testing effectiveness (Phase 2)Ended earlyNCT03101748
What this trial is testing

Neratinib and Paclitaxel With or Without Pertuzumab and Trastuzumab Before Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Breast Cancer

Who this might be right for
Breast Inflammatory CarcinomaLocally Advanced Breast CarcinomaMetastatic Breast Carcinoma+5 more
M.D. Anderson Cancer Center 34
Large-scale testing (Phase 3)Study completedNCT01583426
What this trial is testing

Nanoparticle-based Paclitaxel vs Solvent-based Paclitaxel as Part of Neoadjuvant Chemotherapy for Early Breast Cancer (GeparSepto)

Who this might be right for
Tubular Breast Cancer Stage IIMucinous Breast Cancer Stage IIBreast Cancer Female NOS+5 more
GBG Forschungs GmbH 1,229
Testing effectiveness (Phase 2)Active Not RecruitingNCT03202316
What this trial is testing

Atezolizumab, Cobimetinib, and Eribulin in Treating Patients With Chemotherapy Resistant Metastatic Inflammatory Breast Cancer

Who this might be right for
Recurrent Breast Inflammatory CarcinomaStage IV Breast Inflammatory Carcinoma
M.D. Anderson Cancer Center 37
Load More Results